Exploring the Utility of [18F]3F4AP for Demyelination Imaging in Controls, Neurodegeneration and Traumatic Brian Injury

Clinical trial NCT04710550 · UNKNOWN

Trial details

NCT number: NCT04710550
Sponsor: Massachusetts General Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Brain Injuries, Traumatic Demyelinating Disorder Alzheimer Disease

Start date: 2021-01-25
Primary completion: 2025-12-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.